Institutional investors purchased a net $7.2 million shares of SPPI during the quarter ended December 2015. This may signal that the smart money is gaining interest in this company as the 78.94% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APERIO GROUP LLC Bought 15.0 Thousand shares of Spectrum Pharmaceuticals ...